Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
about
A brief history of the antibiotic era: lessons learned and challenges for the futureEnhancing the antibiotic antibacterial effect by sub lethal tellurite concentrations: tellurite and cefotaxime act synergistically in Escherichia coliChemical synthesis of bacteriophage G4Genetically Engineered Phages: a Review of Advances over the Last DecadeBacteriophages as Weapons Against Bacterial Biofilms in the Food IndustryEcology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm BacteriaBeyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current statusPhage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa InfectionsSynthetic therapeutic gene circuits in mammalian cellsSynthetic biology of antimicrobial discoveryMicrobial biofilm formation: a need to actA role for the bacterial GATC methylome in antibiotic stress survivalSmart DNA Fabrication Using Sound Waves: Applying Acoustic Dispensing Technologies to Synthetic BiologyAntimicrobial-induced DNA damage and genomic instability in microbial pathogensBacteriophages and phage-derived proteins--application approaches'Big things in small packages: the genetics of filamentous phage and effects on fitness of their host'Synthetic gene networks that countNanoscale bacteriophage biosensors beyond phage display.Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureusLoads bias genetic and signaling switches in synthetic and natural systemsGenetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteriaDiversity-based, model-guided construction of synthetic gene networks with predicted functions.Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models.The challenges of informatics in synthetic biology: from biomolecular networks to artificial organismsBioNetCAD: design, simulation and experimental validation of synthetic biochemical networksPhage therapy--constraints and possibilities.Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code.Inhibition of bacterial conjugation by phage M13 and its protein g3p: quantitative analysis and modelHow antibiotics kill bacteria: from targets to networksSynthetic biology: applications come of ageDying for Good: Virus-Bacterium Biofilm Co-evolution Enhances Environmental FitnessBacteriophage-based synthetic biology for the study of infectious diseases.Synthetic biology for translational research.A designer cell-based histamine-specific human allergy profiler.Enhanced killing of antibiotic-resistant bacteria enabled by massively parallel combinatorial geneticsAutomatic design of synthetic gene circuits through mixed integer non-linear programming.Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting.Going viral: next-generation sequencing applied to phage populations in the human gut.Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.
P2860
Q21131155-EBFE30DD-2CA5-47DC-8305-64864DFC1EF2Q21134613-D0DDA1DC-3C9E-4623-B031-392036C0EE3AQ21134974-9B671887-9FD5-431F-B3E4-52E01BA46A51Q26744156-64DABB1A-8A2B-441A-B254-1BB02E7266D8Q26745094-C267D44E-01C0-435F-9AAA-9139BA8327E3Q26786947-3D36333E-AEFC-469A-9404-31C7CCD1A95DQ26795483-9396D1FC-4A4B-4E91-92E0-FF0D2FA73A6FQ26799417-78672EF5-E2D5-4D87-B6E0-8B18F914848AQ26823401-E64740FC-A457-4ECD-B768-4E2A34172BE7Q26826954-D5F1EDA4-FFE4-46B4-83DE-C073CCB988DCQ27001264-8E318A4A-39B8-4D54-A383-A6BD0A6A5107Q27007396-49E0B9DB-106E-4872-9D82-306CE99D8AECQ27316370-F84E7129-531E-48ED-8768-3F4773F69C2AQ27321924-A3C447C8-9957-49D4-97E5-5E28E1D82412Q27693195-3F04867A-85F4-4395-B112-D4288F12B8EAQ28082731-201BAEA3-443B-4A1F-BD62-64DBD30A610EQ28086818-C8A9AA6C-7DD7-481D-9DE7-CA0B82DCD4CFQ28246672-8268363D-844A-4927-9A4B-8DBEBAEE27FEQ28389760-7B80EEBA-860D-4725-8D5A-AEFB459412F1Q28485429-3E6AEDD4-93A0-4EEF-B076-5913D9494BE3Q28541592-D893C27E-B748-409D-9516-34B94BD49193Q28748827-727F8DAD-7359-4275-9F3F-715C1E339B82Q33431823-9FEB962D-BB80-4500-95EB-E54660667CA6Q33571968-0FEA531D-B9C1-4847-A878-FE686B9C37E4Q33605059-AF20616C-2C24-437D-BF66-A82E1080EB4AQ33632042-6E4A7CFE-4C60-463B-A74D-6A4BFB15D1CDQ33667556-AA5FE76C-98BE-4AF0-836C-3A81829D7995Q33768891-E252A7BC-711E-4DBD-9788-42D5C10F8B70Q33921349-F4AD4B9C-5556-4291-9174-DD13989FBA27Q33958766-6029090B-A381-4724-8E27-D4994FE839AEQ33958771-C2494530-33FE-4785-9C24-7284C5779B4AQ34005531-3E0D0AA3-5CA7-438C-A345-8A4B8282E557Q34017160-2B9F9840-F4C9-4CA4-94F0-1A9C9C2F8C10Q34073961-7FD095BE-B1E7-44CA-B2A8-4DAEB815B4B4Q34086352-7BB91B6D-5C29-4771-9988-74E3BA5B2711Q34119921-230D3A0D-932F-43FE-A57F-252F5FE51B15Q34247331-E0207F67-6EF1-4956-BB57-EE070A3DA808Q34311588-2459F087-BBEF-4DAB-9488-072A11C4889CQ34366529-99F1FC97-E781-42FA-8E99-16FD848DEEC6Q34439737-625CA32A-C9D7-415B-AFA1-C0C8BAA4DE6C
P2860
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
@en
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.
@nl
type
label
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
@en
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.
@nl
prefLabel
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
@en
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.
@nl
P2860
P356
P1476
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
@en
P2093
James J Collins
P2860
P304
P356
10.1073/PNAS.0800442106
P407
P50
P577
2009-03-02T00:00:00Z